We report on the transplantation of a cardiac allograft from a donor with p
rolonged exposure to anorexigens. This event allowed us to not only examine
the early pathological alterations that characterize anorexigen-induced va
lvular damage, but to also study the posttransplantation outcome after the
donor heart had been removed from the offending milieu. A donor history of
anorexigen use should be sought, and if detected, careful evaluation for un
derlying valvular disease should be entertained. Early valvulopathy may app
ear clinically mild yet pathologically significant. Our single-case experie
nce also suggests that anorexigen-induced valvulopathy may be a progressive
disorder despite removal of the heart from the causative environment. (C)
1999 by The Society of Thoracic Surgeons.